Matsukuma S, Eguchi H, Wada H, Noda T, Shindo Y, Tokumitsu Y, Matsui H, Takahashi H, Kobayashi S, Nagano H
Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
BJS Open. 2020 Apr;4(2):241-251. doi: 10.1002/bjs5.50258. Epub 2020 Feb 3.
Hepatocellular carcinoma (HCC) with tumour thrombus (TT) in the inferior vena cava (IVC) or right atrium (RA) is a rare advanced disease state with a poor prognosis. The aim of this study was to examine survival after surgical resection.
Patients with HCC and TT of either the IVC or RA, who underwent liver resection between February 1997 and July 2017, were included. Their short- and long-term outcomes and surgical details were analysed retrospectively.
Thirty-seven patients were included; 16 patients had TT in the IVC below the diaphragm, eight had TT in the IVC above the diaphragm, and 13 had TT entering the RA. Twelve patients had advanced portal vein TT (portal vein invasion (Vp) greater than Vp3 and Vp4), ten had bilobar disease, and 12 had extrahepatic disease. There were no in-hospital deaths, although two patients died within 90 days. Median survival did not differ between patients who had resection with curative intent (18·7 months) and those with residual tumour in the lung only (20·7 months), but survival was poor for patients with residual tumour in the liver (8·3 months).
Liver resection with thrombectomy for advanced HCC with TT in the IVC or RA is safe and feasible, leading to moderate survival.
伴有下腔静脉(IVC)或右心房(RA)肿瘤血栓(TT)的肝细胞癌(HCC)是一种罕见的晚期疾病状态,预后较差。本研究的目的是探讨手术切除后的生存率。
纳入1997年2月至2017年7月期间接受肝切除的伴有IVC或RA的HCC和TT患者。对他们的短期和长期结局以及手术细节进行回顾性分析。
共纳入37例患者;16例患者的TT位于膈肌以下的IVC,8例患者的TT位于膈肌以上的IVC,13例患者的TT进入RA。12例患者有进展期门静脉TT(门静脉侵犯(Vp)大于Vp3和Vp4),10例患者有双叶病变,12例患者有肝外病变。尽管有2例患者在90天内死亡,但无院内死亡病例。有治愈性切除意向的患者的中位生存期(18.7个月)与仅肺部有残留肿瘤的患者(20.7个月)之间无差异,但肝脏有残留肿瘤的患者生存期较差(8.3个月)。
对于伴有IVC或RA的TT的晚期HCC,行肝切除联合血栓切除术是安全可行的,可带来适度的生存期。